Navigation Links
3SBio Inc. Schedules 2008 Third Quarter Earnings Release on Monday, November 10, 2008
Date:10/16/2008

Earnings Conference Call to be Held on November 11, 2008 at 5:00 am

(Pacific) / 8:00 am (Eastern) / 9:00 pm (Beijing/Hong Kong)

SHENYANG, China, Oct. 16 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release unaudited financial results for the third quarter ended September 30, 2008 after the US market closes on Monday, November 10, 2008.

The earnings release will be available on the investor relations page of its website at: http://www.3sbio.com/en/News/xShowInfo_nnnn1.aspx?ID=129 .

Following the earnings announcement, 3SBio Inc. senior management will host a conference call at 5:00 am (Pacific) / 8:00 am (Eastern) / 9:00 pm (Beijing/Hong Kong) on Tuesday, November 11, 2008 to discuss its 2008 third quarter financial results and recent business activity. The conference call may be accessed by calling (US) +1 480-629-1990 / (UK) +44 20-8515-2302 / (HK) +852 3009-5027. A telephone replay will be available shortly after the call until November 25, 2008 at (US) +1 303-590-3030 / (UK) +44 207-154-2833, Passcode: 3932898#; and (HK) +852 2287-4304, Passcode: 133110#.

A live webcast of the conference call and replay will be available on the investor relations page of 3SBio's website at: http://www.3sbio.com/en/News/xShowInfo_nnnn1.aspx?ID=129 .

About 3SBio Inc.

3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China. For more information, please visit 3SBio on the web at: http://www.3sbio.com .

For more information, please contact:

Investor Contact:

Kevin Teo, CFO

3SBio Inc.

Tel: +86-24-2581-1820

Investor Relations (US):

Mahmoud Siddig

Taylor Rafferty

Tel: +1-212-889-4350

Investor Relations (HK):

Ruby Yim

Taylor Rafferty

Tel: +852-3196-3712

Media Contact:

Jason Marshall

Taylor Rafferty

Tel: +1-212-889-4350


'/>"/>
SOURCE 3SBio Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. 3SBio Inc. Files for SFDA Approval of High-dose (36,000 IU) EPIAO
2. 3SBio Inc. to Present at the UBS Global Life Sciences Conference
3. 3SBio Inc. Announces Results of Annual General Meeting
4. 3SBio Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference
5. 3SBio Inc. to Hold Annual General Meeting
6. 3SBio Inc. Announces Second Quarter 2008 Results
7. 3SBio Inc. Schedules 2008 Second Quarter Earnings Release On Tuesday, August 12, 2008
8. 3SBio Inc. to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
9. AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China
10. 3SBio Inc. to Present at The Oppenheimer 2nd Annual China Dragon Call Conference
11. 3SBio Inc. Announces First Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... and PETACH TIKVAH, Israel , March ... a leading developer of adult stem cell technologies for ... Chief Executive Officer, will provide an update on new ... nd Annual Neuroscience Biopartnering and Investment Forum, being ... York Academy of Sciences. ...
(Date:3/20/2017)... ... 20, 2017 , ... SSCI and Whitehouse Laboratories, divisions of Albany Molecular Research, ... Sponsored by the Parenteral Drug Association (PDA), the New York Interphex Show will open ... attendance and more than 625 exhibitors, the educational and networking opportunities are extremely valuable. ...
(Date:3/20/2017)... Yorba Linda, CA (PRWEB) , ... March 20, ... ... interference and require expensive and laborious sample preparation methods in order to reduce ... is often underappreciated outside of the area of elemental analysis. , This ...
(Date:3/20/2017)... ... March 20, 2017 , ... ... / linearity test kit has received US FDA 510(k) clearance for use on ... evaluates Heparin Anti-Xa activity in a human plasma matrix. Each VALIDATE® HEPARIN ...
Breaking Biology Technology:
(Date:3/2/2017)... Australian stem cell and regenerative medicine company, ... an agreement with the Monash Lung Biology Network, a ... and Department of Pharmacology at Monash University, ... to support the use of Cymerus™ mesenchymal stem cells ... Asthma is a chronic, long term lung condition recognised ...
(Date:2/28/2017)... , Feb. 28, 2017   Acuant , ... software globally, announces significant enhancements to new and core ... 2016. New products include mobile and desktop Acuant FRM ... TM - a real time manual review of ... idScan® technology provides the fastest and most accurate capture ...
(Date:2/28/2017)... BARCELONA , Spanien, 27. Februar 2017 /PRNewswire/ ... durch Iris-Scan, wird seine erstklassige biometrische Lösung ... Snapdragon™ 835 mit X16 LTE auf dem ... 2. März) am Qualcomm-Stand in Halle 3, ... 835-Prozessor beinhaltet die Sicherheitsplattform Qualcomm Haven™ – ...
Breaking Biology News(10 mins):